NCT06863714View on ClinicalTrials.gov

Peritonsillar Bupivacaine Infiltration After Tonsillectomy In Children

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 10, 2023

Primary Completion Date

September 10, 2024

Study Completion Date

October 20, 2024

Conditions
Post Operative DeliriumPost Operative Pain
Interventions
DRUG

peritonsillar bupivacaine injection

Peritonsillar injection was superficially administered to the superior and inferior peritonsillar regions in a volume of 2-5 ml. A 23 Gouge needle syringe was used for injection. A 0.5% Bupivacaine was administered at a dose of 1 mg/kg (maximum dose of 25 mg)

Trial Locations (1)

34371

Sisli Hamidiye Etfal Training Hospital, Istanbul

All Listed Sponsors
lead

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

NCT06863714 - Peritonsillar Bupivacaine Infiltration After Tonsillectomy In Children | Biotech Hunter | Biotech Hunter